MHIP vs. XBI

Last updated Jul 8, 2026

MHIP (Milliman Healthcare Inflation Plus ETF) and XBI (SPDR S&P Biotech ETF) are both Health & Biotech Equities funds. MHIP is actively managed, while XBI is passively managed. A 0.54 correlation means they provide meaningful diversification when combined. MHIP charges 0.55%/yr vs 0.35%/yr for XBI.

Performance

MHIP vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Milliman Healthcare Inflation Plus ETF (MHIP) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

MHIP

• 1D: 0.26%
• 1M: 2.51%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

XBI

• 1D: 1.90%
• 1M: 27.48%
• 6M: 34.35%
• YTD: 34.53%
• 1Y: 96.96%
• 3Y*: 26.34%
• 5Y*: 4.57%
• 10Y*: 11.18%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MHIP vs. XBI - Yearly Performance Comparison

	2026 (YTD)
MHIP Milliman Healthcare Inflation Plus ETF	1.64%
XBI SPDR S&P Biotech ETF	19.04%

Correlation

The correlation between MHIP and XBI is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026	0.54

Return for Risk

MHIP vs. XBI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MHIP

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

XBI

XBI Risk / Return Rank: 96
XBI Sharpe Ratio Rank: 97
XBI Sortino Ratio Rank: 95
XBI Omega Ratio Rank: 93
XBI Calmar Ratio Rank: 98
XBI Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MHIP vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Milliman Healthcare Inflation Plus ETF (MHIP) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	MHIP	XBI	Difference
Sharpe ratio: Return per unit of total volatility	—	3.66	—
Sortino ratio: Return per unit of downside risk	—	4.50	—
Omega ratio: Gain probability vs. loss probability	—	1.55	—
Calmar ratio: Return relative to maximum drawdown	—	10.03	—
Martin ratio: Return relative to average drawdown	—	29.66	—

Drawdowns

MHIP vs. XBI - Drawdown Comparison

The maximum MHIP drawdown since its inception was -3.09%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for MHIP and XBI.

Drawdown Indicators

	MHIP	XBI	Difference
Max Drawdown Largest peak-to-trough decline	-3.09%	-63.89%	+60.80%
Max Drawdown (1Y) Largest decline over 1 year	—	-9.72%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-32.99%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-54.00%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-63.89%	—
Current Drawdown Current decline from peak	0.00%	-5.19%	+5.19%
Average Drawdown Average peak-to-trough decline	-1.28%	-20.91%	+19.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.28%	—

Volatility

Volatility by Period

	MHIP	XBI	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	8.24%	—
Volatility (6M) Calculated over the trailing 6-month period	—	21.35%	—
Volatility (1Y) Calculated over the trailing 1-year period	11.86%	26.71%	-14.85%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	11.86%	32.30%	-20.44%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	11.86%	31.93%	-20.07%

MHIP vs. XBI - Expense Ratio Comparison

MHIP has a 0.55% expense ratio, which is higher than XBI's 0.35% expense ratio.

Dividends

MHIP vs. XBI - Dividend Comparison

MHIP has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.35%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MHIP Milliman Healthcare Inflation Plus ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
XBI SPDR S&P Biotech ETF	0.35%	0.37%	0.15%	0.02%	0.00%	0.04%	0.20%	0.00%	0.28%	0.24%	0.26%	0.61%

Frequently Asked Questions

Can I hold both MHIP and XBI in my portfolio?

MHIP and XBI have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, MHIP or XBI?

On fees, XBI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, MHIP or XBI?

XBI is cheaper with a 0.35% expense ratio, compared with 0.55% for MHIP.

Which ETF pays a higher dividend yield, MHIP or XBI?

XBI has the higher dividend yield at 0.35%, compared with 0.00% for MHIP.

What is the main difference between MHIP and XBI?

They also come from different issuers: Milliman and State Street. Their fees differ too: 0.55% for MHIP and 0.35% for XBI.